Todd Bazemore
President bij KALA BIO, INC.
Vermogen: 8 $ op 31-03-2024
Profiel
Todd Bazemore is an Independent Director at Pulmatrix, Inc. since 2020.
He is also the President & Chief Operating Officer at KALA BIO, Inc. since 2017.
Previously, he held positions such as Vice President-Managed Markets at Sumitomo Pharma America, Inc. from 2012 to 2013, Chief Commercial Officer & Executive VP at Dyax Corp.
from 2014 to 2016, Chief Operating Officer & Executive Vice President at Santhera Pharmaceuticals Holding AG from 2016 to 2017, and Chief Operating Officer & Executive Vice President at Santhera Pharmaceuticals (USA), Inc. from 2016 to 2017.
Mr. Bazemore completed his undergraduate degree at the University of Massachusetts Lowell.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KALA BIO, INC.
0.00% | 04-01-2024 | 1 ( 0.00% ) | 8 $ | 31-03-2024 |
PULMATRIX INC
-.--% | 25-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Todd Bazemore
| Bedrijven | Functie | Begin |
|---|---|---|
| KALA BIO, INC. | President | 16-12-2021 |
| PULMATRIX, INC. | Director/Board Member | 01-10-2020 |
Eerdere bekende functies van Todd Bazemore
| Bedrijven | Functie | Einde |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Chief Operating Officer | 01-11-2017 |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Chief Operating Officer | 01-11-2017 |
| DYAX CORP. | Corporate Officer/Principal | 22-01-2016 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01-09-2013 |
Opleiding van Todd Bazemore
| University of Massachusetts Lowell | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| KALA BIO, INC. | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| PULMATRIX, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Health Technology |
